481 related articles for article (PubMed ID: 11318594)
1. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
[TBL] [Abstract][Full Text] [Related]
2. The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
Lu PD; Galanakis DK; Ghebrehiwet B; Peerschke EI
Clin Immunol; 1999 Mar; 90(3):360-7. PubMed ID: 10075865
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R, associate to form a complex.
Ghebrehiwet B; Lu PD; Zhang W; Keilbaugh SA; Leigh LE; Eggleton P; Reid KB; Peerschke EI
J Immunol; 1997 Aug; 159(3):1429-36. PubMed ID: 9233640
[TBL] [Abstract][Full Text] [Related]
4. gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes.
Braun L; Ghebrehiwet B; Cossart P
EMBO J; 2000 Apr; 19(7):1458-66. PubMed ID: 10747014
[TBL] [Abstract][Full Text] [Related]
5. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection.
Ghebrehiwet B; Peerschke EI
Mol Immunol; 2004 Jun; 41(2-3):173-83. PubMed ID: 15159063
[TBL] [Abstract][Full Text] [Related]
6. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis.
Ghebrehiwet B; Kew RR; Gruber BL; Marchese MJ; Peerschke EI; Reid KB
J Immunol; 1995 Sep; 155(5):2614-9. PubMed ID: 7650391
[TBL] [Abstract][Full Text] [Related]
7. Distribution of receptors of collagen and globular domains of C1q in human lung fibroblasts.
Narayanan AS; Lurton J; Raghu G
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):84-90. PubMed ID: 9224213
[TBL] [Abstract][Full Text] [Related]
8. Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.
Cassetta L; Fortunato O; Adduce L; Rizzi C; Hering J; Rovere-Querini P; Bianchi ME; Alfano M; Poli G
AIDS; 2009 Mar; 23(5):567-77. PubMed ID: 19194273
[TBL] [Abstract][Full Text] [Related]
9. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
[TBL] [Abstract][Full Text] [Related]
10. Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells.
Gomatos PJ; Stamatos NM; Gendelman HE; Fowler A; Hoover DL; Kalter DC; Burke DS; Tramont EC; Meltzer MS
J Immunol; 1990 Jun; 144(11):4183-8. PubMed ID: 2341717
[TBL] [Abstract][Full Text] [Related]
11. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
[TBL] [Abstract][Full Text] [Related]
12. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
Caporuscio F; Tafi A; González E; Manetti F; Esté JA; Botta M
Bioorg Med Chem Lett; 2009 Nov; 19(21):6087-91. PubMed ID: 19783140
[TBL] [Abstract][Full Text] [Related]
13. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
15. gC1q-R/p33: structure-function predictions from the crystal structure.
Ghebrehiwet B; Jesty J; Peerschke EI
Immunobiology; 2002 Sep; 205(4-5):421-32. PubMed ID: 12396004
[TBL] [Abstract][Full Text] [Related]
16. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.
Iyengar S; Schwartz DH; Hildreth JE
J Immunol; 1999 May; 162(10):6263-7. PubMed ID: 10229873
[TBL] [Abstract][Full Text] [Related]
17. Interaction of an anti-HIV peptide, T22, with gp120 and CD4.
Tamamura H; Otaka A; Murakami T; Ishihara T; Ibuka T; Waki M; Matsumoto A; Yamamoto N; Fujii N
Biochem Biophys Res Commun; 1996 Feb; 219(2):555-9. PubMed ID: 8605026
[TBL] [Abstract][Full Text] [Related]
18. Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes.
Hasunuma T; Tsubota H; Watanabe M; Chen ZW; Lord CI; Burkly LC; Daley JF; Letvin NL
J Immunol; 1992 Mar; 148(6):1841-6. PubMed ID: 1371792
[TBL] [Abstract][Full Text] [Related]
19. C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors.
Khalkhali-Ellis Z; Bulla GA; Schlesinger LS; Kirschmann DA; Moore TL; Hendrix MJ
J Immunol; 1999 Oct; 163(8):4612-20. PubMed ID: 10510406
[TBL] [Abstract][Full Text] [Related]
20. Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation.
Chen A; Gaddipati S; Hong Y; Volkman DJ; Peerschke EI; Ghebrehiwet B
J Immunol; 1994 Aug; 153(4):1430-40. PubMed ID: 8046223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
